LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 139 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 6.44 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $67,445,000 | -44.0% | 4,100 | -51.2% | 0.01% | -39.1% |
Q1 2017 | $120,456,000 | +7.5% | 8,400 | +3.7% | 0.02% | +4.5% |
Q4 2016 | $112,023,000 | -25.3% | 8,100 | -2.4% | 0.02% | -15.4% |
Q3 2016 | $149,981,000 | +30.6% | 8,300 | +3.8% | 0.03% | +30.0% |
Q2 2016 | $114,800,000 | – | 8,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |